[go: up one dir, main page]

NO20045215L - Anvendelse av tio-oxindolderivater for behandling av hudlidelser - Google Patents

Anvendelse av tio-oxindolderivater for behandling av hudlidelser

Info

Publication number
NO20045215L
NO20045215L NO20045215A NO20045215A NO20045215L NO 20045215 L NO20045215 L NO 20045215L NO 20045215 A NO20045215 A NO 20045215A NO 20045215 A NO20045215 A NO 20045215A NO 20045215 L NO20045215 L NO 20045215L
Authority
NO
Norway
Prior art keywords
thio
skin disorders
treatment
oxindole derivatives
oxindole
Prior art date
Application number
NO20045215A
Other languages
English (en)
Inventor
Andrew Fensome
Diane Deborah Harrison
Richard Craig Winneker
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20045215L publication Critical patent/NO20045215L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Foreliggende oppfinnelse tilveiebringer metoder for behandling av hudlidelser som omfatter levering til et pattedyr av et preparat inneholdende en forbindelse med formel I eller tautomerer derav i et regime. Spesifikt er metoder for behandling av acne, hirsutisme og et preparat for kondisjonering av huden beskrevet.
NO20045215A 2002-06-25 2004-11-29 Anvendelse av tio-oxindolderivater for behandling av hudlidelser NO20045215L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39191302P 2002-06-25 2002-06-25
PCT/US2003/019791 WO2004000227A2 (en) 2002-06-25 2003-06-23 Use of thio-oxindole derivatives in treatment of skin disorders

Publications (1)

Publication Number Publication Date
NO20045215L true NO20045215L (no) 2005-03-17

Family

ID=30000776

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20045215A NO20045215L (no) 2002-06-25 2004-11-29 Anvendelse av tio-oxindolderivater for behandling av hudlidelser

Country Status (17)

Country Link
US (1) US7115649B2 (no)
EP (1) EP1515680A4 (no)
JP (1) JP2005535625A (no)
KR (1) KR20050012831A (no)
CN (1) CN1662206A (no)
AR (1) AR040338A1 (no)
AU (1) AU2003258952A1 (no)
BR (1) BR0312092A (no)
CA (1) CA2489810A1 (no)
EC (1) ECSP055575A (no)
IL (1) IL165394A0 (no)
MX (1) MXPA04012418A (no)
NO (1) NO20045215L (no)
RU (1) RU2005101624A (no)
TW (1) TW200401637A (no)
WO (1) WO2004000227A2 (no)
ZA (1) ZA200410401B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6355648B1 (en) * 1999-05-04 2002-03-12 American Home Products Corporation Thio-oxindole derivatives
US6509334B1 (en) * 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
US6391907B1 (en) 1999-05-04 2002-05-21 American Home Products Corporation Indoline derivatives
US6407101B1 (en) 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
UA73119C2 (en) 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
RU2005101635A (ru) * 2002-06-25 2005-08-10 Уайт (Us) Применение производных тиооксиндола в терапии гормонозависимых состояний
CN1938298B (zh) * 2004-04-08 2013-02-06 惠氏公司 减少硫代酰胺杂质的方法
ATE413398T1 (de) * 2004-04-08 2008-11-15 Wyeth Corp Thioamidderivate als progesteronrezeptormodulatoren
BRPI0510260A (pt) * 2004-04-27 2007-10-23 Wyeth Corp método para purificar um composto, e, kit farmacêutico
GT200500185A (es) * 2004-08-09 2006-04-10 Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos
MY158766A (en) 2005-04-11 2016-11-15 Xenon Pharmaceuticals Inc Spiro-oxindole compounds and their uses as therapeutic agents
MY145694A (en) 2005-04-11 2012-03-30 Xenon Pharmaceuticals Inc Spiroheterocyclic compounds and their uses as therapeutic agents
CA2665698A1 (en) 2006-10-12 2008-05-22 Xenon Pharmaceuticals Inc. Use of spiro-oxindole compounds as therapeutic agents
CN101636157A (zh) * 2007-01-12 2010-01-27 康乃尔研究基金会有限公司 作为抗菌干预的新型靶的腺苷酰环化酶
CN101680026A (zh) * 2007-01-12 2010-03-24 康乃尔研究基金会有限公司 作为真核病原体感染治疗的新型靶的腺苷酰环化酶
US8263606B2 (en) 2008-10-17 2012-09-11 Xenon Pharmaceuticals Inc. Spiro-oxindole compounds and their use as therapeutic agents
EP2350091B1 (en) 2008-10-17 2015-06-03 Xenon Pharmaceuticals Inc. Spiro-oxindole compounds and their use as therapeutic agents
AR077252A1 (es) 2009-06-29 2011-08-10 Xenon Pharmaceuticals Inc Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
MY165579A (en) 2009-10-14 2018-04-05 Xenon Pharmaceuticals Inc Synthetic methods for spiro-oxindole compounds
WO2011106729A2 (en) 2010-02-26 2011-09-01 Xenon Pharmaceuticals Inc. Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents
KR101278271B1 (ko) * 2011-08-02 2013-06-25 충남대학교산학협력단 인돌린-2-티온 유사체를 함유한 미백용 조성물
WO2014025942A1 (en) 2012-08-09 2014-02-13 Emory University Nmda receptor modulators and uses related thereto
US9682033B2 (en) 2015-02-05 2017-06-20 Teva Pharmaceuticals International Gmbh Methods of treating postherpetic neuralgia with a topical formulation of a spiro-oxindole compound

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US92711A (en) * 1869-07-20 e d w a r d s
US169198A (en) * 1875-10-26 Improvement in treating quicksilver-ore
WO1985000519A1 (en) 1983-07-29 1985-02-14 Duke University Method of treating androgen-related disorders
DE4335876A1 (de) * 1993-10-17 1995-04-20 Schering Ag Kombination von Progesteronantagonisten und Antiöstrogenen mit partialer agonistischer Wirkung für die Hormonsubstitutions-Therapie für peri- und postmenopausale Frauen
AU755165B2 (en) * 1998-10-23 2002-12-05 Aventis Pharma S.A. Preparations for topical application of substances having antiandrogenic effect
EP1139754A4 (en) 1998-12-31 2002-12-18 Sugen Inc 3-HETEROARYLIDENYL-2-INDOLINONE COMPOUNDS FOR MODULATION OF PROTEIN KINASE ACTIVITY AND IN CANCER CHEMOTHERAPY
US6391907B1 (en) 1999-05-04 2002-05-21 American Home Products Corporation Indoline derivatives
US6407101B1 (en) 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
US6355648B1 (en) 1999-05-04 2002-03-12 American Home Products Corporation Thio-oxindole derivatives
JP2003525796A (ja) 1999-08-26 2003-09-02 オートモーティブ システムズ ラボラトリー インコーポレーテッド 磁気センサ
US6566372B1 (en) * 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
EP1272484B1 (en) 2000-04-10 2005-07-20 Pfizer Products Inc. Benzoamide piperidine compounds as substance p antagonists
US7119207B2 (en) * 2000-04-10 2006-10-10 Pfizer Inc Benzoamide piperidine containing compounds and related compounds
UA73119C2 (en) 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
WO2006006555A1 (ja) * 2004-07-12 2006-01-19 Rohm Co., Ltd. 半導体発光素子

Also Published As

Publication number Publication date
BR0312092A (pt) 2005-03-22
ZA200410401B (en) 2006-05-31
TW200401637A (en) 2004-02-01
IL165394A0 (en) 2006-01-15
RU2005101624A (ru) 2005-06-27
ECSP055575A (es) 2005-04-18
WO2004000227A3 (en) 2004-04-08
WO2004000227A2 (en) 2003-12-31
CN1662206A (zh) 2005-08-31
EP1515680A2 (en) 2005-03-23
AU2003258952A1 (en) 2004-01-06
KR20050012831A (ko) 2005-02-02
US20040006122A1 (en) 2004-01-08
MXPA04012418A (es) 2005-04-19
CA2489810A1 (en) 2003-12-31
AR040338A1 (es) 2005-03-30
EP1515680A4 (en) 2005-09-21
US7115649B2 (en) 2006-10-03
JP2005535625A (ja) 2005-11-24

Similar Documents

Publication Publication Date Title
NO20045215L (no) Anvendelse av tio-oxindolderivater for behandling av hudlidelser
NO20061454L (no) Compounds having CRTH2 antagonist activity
NO20084912L (no) Bisykliske derivater som CETP-inhibitorer
NO20050828L (no) lndol-3-svovelderivater
NO20050795L (no) Forbindelser, blandinger og fremgangsmater for utnyttelse av samme
NO20071549L (no) Nye benzofuserte heteroalrylsulfamidderivater, anvendelige som anti-krampemidler
NO20051100L (no) Pyrazolsammensetninger anvendelige som GSK-3-inhibitorer
NO20075082L (no) Pyridin-3-karboksamidderivater som CB1-inversagonister
NO20055863L (no) W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer
NO20025601L (no) Arylmetylaminderivater for anvendelse som tryptaseinhibitorer
NO20070933L (no) Indazoler anvendbare i behandling av kardiovaskulaere sykdommer
WO2005110994A8 (en) Substituted pyrazolyl urea derivatives useful in the treatment of cancer
NO20050525L (no) Benzimidazol-1-yl-tiofenforbindelser for behandling av cancer
NO20072352L (no) Forbindelser og sammensetninger som inhibitorer av cannabinoidreceptor 1-aktivitet
NO20082496L (no) Pyrazinderivater
NO20045677L (no) Inhibitorer av JAK- og CDK2-proteinkinaser
NO20081482L (no) Delta- og epsilon-krystallformer for imatinibmesylat
NO20066055L (no) Pyridinderivater
NO20055649L (no) Substituert dihydrokinazolin med antiviale egenskaper
NO20072608L (no) Biaryloksymetylarenkarboksylsyrer
NO20052888L (no) Diamintriazoler anvendelige som inhibitorer av proteinkinaser
NO20070049L (no) Pyrrolotriazinderivater anvendelig for behandling av hyperproliferative forstyrrelser og sykdommer assosiert med angiogenese
NO20052028L (no) Pyridinderivater som CB2 reseptor modulatorer
NO20045214L (no) Cyklotiokarbamatderivater som BR modulatorere og anvendelse derav for behandling av hudlidelser
NO20062020L (no) 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application